FDA Proposes $5 Million Budget to Regulate CBD in 2021

President Trump’s budget proposal for the 2021 fiscal year, which is set to be presented to Congress next year, should he gain re-election, includes $6.2 billion in overall funding for the Food and Drug Administration (“FDA”). This proposal includes a $5 million-line item for FDA to continue … Read more about FDA Proposes $5 Million Budget to Regulate CBD in 2021

FDA Recognizes the Need for CBD Regulation

On February 26, 2020 the Food and Drug Administration’s (“FDA”) new commissioner, Dr. Stephen Hahn, acknowledged the growing consumer demand for CBD products. “People are using these [CBD] products,” Hahn said in his first public speech regarding CBD since taking office in December. “We are not … Read more about FDA Recognizes the Need for CBD Regulation

New Bill Proposes Solution to CBD Regulation

On January 13, 2020, the chairman of the U.S. House Committee on Agriculture, Representative Collin Peterson (D-MN), introduced a bill to address one of the largest issues in the burgeoning hemp industry – the regulation of cannabidiol (“CBD”). H.R.5587 aims to amend existing legislation to grant … Read more about New Bill Proposes Solution to CBD Regulation

D.C. Court Supports FDA Regulation of E-Cigs & Vape Products

On 10, December 2019, the United States Court of Appeals for the D.C. Circuit ruled in support of actions by the Food and Drug Administration (“FDA”) on the regulation and classification of electronic nicotine delivery system (“ENDS”) products like electronic cigarettes and vaping devices. The … Read more about D.C. Court Supports FDA Regulation of E-Cigs & Vape Products

Westword Publishes Managing Partner’s Article on CBD & Schedule I

Nearly a year after the passing of the Agriculture Improvement Act of 2018 (“2018 Farm Bill”), the industrial hemp and cannabidiol (“CBD”) markets are booming, yet ingestible products are still illegal according to the federal government. With mounting pressure on the U.S. Food and Drug … Read more about Westword Publishes Managing Partner’s Article on CBD & Schedule I

New Screening Guidelines for Fecal Transplants Could Save Lives

The Food and Drug Administration (“FDA”) has recently set guidelines on an increasingly common medical treatment: fecal microbiota transplants, or FMTs. The recent announcement comes after a patient died in June after receiving an FMT that contained drug-resistant bacteria.1 Unfortunately, up until … Read more about New Screening Guidelines for Fecal Transplants Could Save Lives

Recent FTC Warning Letters Target CBD Medical Claims

September 10, 2019, the U.S. Federal Trade Commission (“FTC”) issued a news release announcing the recent distribution of warning letters to three companies advertising cannabidiol (“CBD”) products as a medical treatment option for a range of various illnesses. Cautioning that such unsubstantiated … Read more about Recent FTC Warning Letters Target CBD Medical Claims

Proposed California CBD Bill Suspended

Contrary to the bill’s projected outcome from earlier in the summer, California lawmakers will not make a decision on Assembly Bill-228 (“AB 228”) this year as the bill has stalled in the state legislature despite broad bipartisan interest and consumer support. Previously expected to be signed into … Read more about Proposed California CBD Bill Suspended